
Mohammad Jad Moussa/X
Mar 7, 2024, 17:22
Mohammad Jad Moussa: The new EVP ‘fissure’ challenges the dichotomy of cisplatin/platinum fitness
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on X/Twitter:
“Our Iceberg Model in Imagining the New 1L Treatment Paradigm of metastatic urothelial cancer with Matt Campbell and Omar Alhalabi.
The new EVP ‘fissure’ challenges the dichotomy of cisplatin/platinum fitness. What lurks beneath the surface?
Emerging biomarkers and treatment strategies.”
Proceed to the article.
Source: Mohammad Jad Moussa/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 17, 2025, 11:25
Apr 17, 2025, 10:30
Apr 17, 2025, 10:14
Apr 17, 2025, 10:01
Apr 17, 2025, 09:54
Apr 17, 2025, 09:27
Apr 17, 2025, 08:24